 |
|
|
| |
Efficacy and Safety of Islatravir in Combination With Doravirine Through
144 Weeks for Treatment-Naïve Adults With HIV-1 Infection in a Phase 2b Trial
|
| |
| |
EACS 2021 Oct 27-30
Jean-Michel Molina,1 Yazdan Yazdanpanah,2 Alejandro Afani Saud,3 Christopher Bettacchi,4 Carolina Chahin Anania,5 Stephanie Olsen Klopfer,6 Anjana Grandhi,6 Karen Eves,6 Deborah Hepler,6 Rima Lahoulou,7 Todd Correll6
1University of Paris and Hôpital Saint-Louis-Lariboisière, Paris, France; 2Bichat Hospital, Paris, France; 3University of Chile, Santiago, Chile; 4North Texas Infectious Diseases Consultants, Dallas, TX, USA; 5Hospital Hernán Henríquez Aravena of Temuco, Temuco, Chile; 6Merck & Co., Inc., Kenilworth, NJ, USA; 7MSD France, Puteaux, France
|
| |
|
|
|
|
|
